000 | 01632 a2200505 4500 | ||
---|---|---|---|
005 | 20250514005716.0 | ||
264 | 0 | _c20010913 | |
008 | 200109s 0 0 eng d | ||
022 | _a0002-9378 | ||
024 | 7 |
_a10.1067/mob.2001.115106 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPorter, A E | |
245 | 0 | 0 |
_aOptimization of cytokine stability in stored amniotic fluid. _h[electronic resource] |
260 |
_bAmerican journal of obstetrics and gynecology _cAug 2001 |
||
300 |
_a459-62 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAmniotic Fluid _xchemistry |
650 | 0 | 4 | _aAprotinin |
650 | 0 | 4 | _aCryopreservation |
650 | 0 | 4 |
_aCytokines _xanalysis |
650 | 0 | 4 | _aDrug Stability |
650 | 0 | 4 |
_aEndothelial Growth Factors _xanalysis |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGestational Age |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterleukin-6 _xanalysis |
650 | 0 | 4 | _aKaryotyping |
650 | 0 | 4 |
_aLymphokines _xanalysis |
650 | 0 | 4 | _aPregnancy |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 |
_aRibonuclease, Pancreatic _xanalysis |
650 | 0 | 4 | _aTemperature |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTissue Preservation |
650 | 0 | 4 | _aVascular Endothelial Growth Factor A |
650 | 0 | 4 | _aVascular Endothelial Growth Factors |
650 | 0 | 4 |
_aalpha-Fetoproteins _xanalysis |
700 | 1 | _aAuth, J | |
700 | 1 | _aPrince, M | |
700 | 1 | _aGhidini, A | |
700 | 1 | _aBrenneman, D E | |
700 | 1 | _aSpong, C Y | |
773 | 0 |
_tAmerican journal of obstetrics and gynecology _gvol. 185 _gno. 2 _gp. 459-62 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1067/mob.2001.115106 _zAvailable from publisher's website |
999 |
_c11443324 _d11443324 |